| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sangamo Therapeutics, Inc (SGMO) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. SGMO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $331.6K | - | |
| Other | 696.7K | $121.9K | - | |
| VP | 647.4K | $113.3K | - | |
| VP | 328.7K | $57.5K | - | |
| Other | 235.3K | $41.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2015 | Ando Dale G | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $12.93 | $193,950.00 | -13.6% | |
| Feb 3, 2015 | Ringo William R | Director | Sale+OE | 2,200 | $12.70 | $27,940.00 | -73.3% | |
| Feb 2, 2015 | Gregory Philip D | SVP Of Research &CSO | Sale+OE | 15,000 | $12.86 | $192,829.50 | -11.4% | |
| Jan 16, 2015 | Lanphier Edward O II | President &CEO | Sale+OE | 25,000 | $14.22 | $355,621.64 | -3.4% | |
| Jan 12, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 12,000 | $15.87 | $190,450.00 | -2.8% | |
| Jan 5, 2015 | Ando Dale G | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $15.19 | $227,853.54 | -7.3% | |
| Jan 5, 2015 | Ringo William R | Director | Sale+OE | 2,200 | $15.20 | $33,429.88 | -73.3% | |
| Jan 5, 2015 | Larson John William | Director | Sale+OE | 15,000 | $15.10 | $226,549.50 | -6.5% | |
| Jan 2, 2015 | Gregory Philip D | SVP, Research &CSO | Sale+OE | 15,000 | $15.78 | $236,664.00 | -11.4% |